Mount Sinai Health System and Renalytix AI afnnounced the formation of Kantaro Biosciences, a Mount Sinai venture, to develop and scale production and distribution of a test kit based on the Mount Sinai-developed high-performance serologic assay for SARS-CoV-2 antibodies. 

Mount Sinai Health System

New York

Mount Sinai Health System startup from New York, United States is ranked 89 out of 2450 worldwide and 36 from the 748 startups in United States. See more information and additional rankings on the StartupBlink Global Ecosystem Map